Proud Sponsor of the Organization of Women in International Trade - Badge

Antitrust Lawyer Blog

USTR Will Open an Online Portal for Section 301 List 3 Exclusion Process
Doyle, Barlow & Mazard PLLC

On June 20, 2019 the Office of the United States Trade Representative (“USTR”) announced an exclusion process for tariffs imposed on September 2018 (“List 3”) pursuant to the U.S. Section 301 action against China. This announcement was followed by a notice published in the Federal Register. Through this exclusion process, parties will be able to…

Continue reading ›
Canon and Toshiba Settle HSR Act Violation Case
Doyle, Barlow & Mazard PLLC

On June 10, 2019, the U.S. Department of Justice (DOJ) Antitrust Division filed a complaint and reached a settlement with Canon and Toshiba for violating the Hart-Scott-Rodino (HSR) Act during Canon’s acquisition of a Toshiba subsidiary. The HSR Act requires companies to notify the DOJ and the Federal Trade Commission (FTC) of certain mergers and…

Continue reading ›
Additional Tariffs on Mexican Imports: A “Creative” Approach to Both Immigration Policy and Negotiation Strategy that Will Likely Have Widespread Consequences
Doyle, Barlow & Mazard PLLC

On May 30, 2019 President Trump announced via Twitter that the United States (U.S.) will impose tariffs on Mexican imports to prompt Mexico to significantly reduce immigration to the U.S.  President Trump will impose these additional tariffs in the context of rapidly increasing immigration from Mexico to the U.S. over the past months. In declaring…

Continue reading ›
Trump Administration Lifts Tariffs on Imports of Steel and Aluminum from Canada and Mexico
Doyle, Barlow & Mazard PLLC

President Trump announced an agreement to remove the tariffs imposed on steel and aluminum imports from Canada and Mexico as part of the renegotiated North American Free Trade Agreement (“NAFTA”).  The current tariffs included a 25 percent rate on steel imports and 10 percent on aluminum imports. In response to the United States’ steel and…

Continue reading ›
China Retaliates Against U.S. Tariffs
Doyle, Barlow & Mazard PLLC

Last week, the Trump Administration raised tariffs to 25% on $200 billion worth of goods that previously were subject to 10% tariffs.  The increased rate in tariffs were brought on as a result of accusations that the Chinese delegation to the trade negotiations back-tracked on previous agreements, and the increase was meant to ratchet up…

Continue reading ›
Updates in International Trade
Doyle, Barlow & Mazard PLLC

The last few weeks brought a flurry of developments regarding international trade.  Two petitions recently were filed with the US International Trade Commission (“ITC”). On April 30th, Hirsh Industries filed an antidumping (“AD”) and countervailing duty (“CVD”) petition on imports of certain vertical metal file cabinets from China.  The petition covers metal filing cabinets containing…

Continue reading ›
CIT Decision on Constitutionality of Section 232
Doyle, Barlow & Mazard PLLC

A lawsuit commenced by the American Institute for International Steel (“AIIS”) regarding the constitutionality of Section 232 before the Court of International Trade (“CIT”) has been decided.  A three-judge panel decided that Section 232 was not unconstitutional. The plaintiffs argued that Section 232 of the Trade Expansion Act of 1962, as amended, did not properly…

Continue reading ›
Allegeran Wins Motion to Dismiss Regarding Questionable Rebate Practices
Doyle, Barlow & Mazard PLLC

On March 22, 2019, Judge John Michael Vazquez of the United States District Court for the District of New Jersey granted Allergan’s motion to dismiss Shire’s antitrust complaint that Allergan monopolized the Medicare Part D dry eye disease (“DED”) treatment market through its contracting practices with insurers including rebates based on a bundled portfolio of…

Continue reading ›
Trump Administration Acts to Lower Medicare Prescription Drug Prices
Doyle, Barlow & Mazard PLLC

The rising prices of existing and new brand prescription drugs could have serious consequences for tax payers and the 44 million seniors who rely on Medicare.  In order to rein in those costs, it’s vital for the Administration to encourage the use of generic drugs and biosimilars. While Congress has been grabbing the headlines by…

Continue reading ›
Aerial view of Washington DC cityscape from Arlington Virginia USA.

Contact Us

Fill out the form or call us at (202) 589-1834 to schedule your consultation.